Kaleido Biosciences, Inc.
KLDODelisted Apr 18, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001751299
Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Kaleido Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 500.7K | 0 | −500.7K (−100.0%) |
| Value | $31.0K | $0 | −$31.0K (−100.0%) |
New holders (0)
Institutions that held Kaleido Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (3)
Institutions that held Kaleido Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Artal Group S.A. | 500,500 | $31.0K |
| Captrust Financial Advisors | 129 | $0 |
| Close Asset Management Ltd | 100 | $0 |